Global G-Protein Coupled Receptors Market

G-Protein Coupled Receptors Comprehensive Study by Type (Cell Lines, Detection Kits, Cell Culture Reagents, Ligands), Application (Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Respiratory Research, Inflammation Research, Other Application), Assay (CAMP Functional Assays, Calcium Functional Assays, β-Arrestin Functional Assays, Radioligand Binding and GTPγS Functional Assays, Internalization Assays, Trafficking Assays, Other Assays) Players and Region - Global Market Outlook to 2030

G-Protein Coupled Receptors Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About G-Protein Coupled Receptors
G-protein coupled receptor (GPCR), also called seven-trans membrane receptor or heptahelical receptor, is a protein located in the cell membrane that binds extracellular substances and transmits signals from these substances to an intracellular molecule called a G protein (guanine nucleotide-binding protein). GPCRs are found in the cell membranes of a wide range of organisms, including mammals, plants, microorganisms, and invertebrates. G protein-coupled receptors (GPCRs), also known as 7TM receptors, heptahelical receptors, serpentine receptors, and G protein-linked receptors (GPLR), are cell surface receptors that detect molecules outside the cell and activate cellular responses. They are known as seven-transmembrane receptors because they pass through the cell membrane seven times when they bind to G proteins. Ligands can bind to the extracellular N-terminus and loops of proteins (for example, glutamate receptors) or to the binding site within transmembrane helices (Rhodopsin-like family). Agonists activate all of them, though spontaneous auto-activation of an empty receptor has been observed. Only eukaryotes, including yeast, choanoflagellates, and animals, have G protein-coupled receptors.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The players in global G-protein coupled receptors (GPCR) market are focusing on the expansion of their product portfolios, by adopting inorganic growth strategies, such as acquisitions, mergers, and partnerships. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Thermo Fisher Scientific, Inc (United States), Merck Group (Germany), PerkinElmer, Inc (United States), Cisbio Bioassays (France), Enzo Life Sciences, Inc. (United States), Promega Corporation (United States), Abcam plc (United Kingdom), Qiagen (Germany), BD (United States) and HD BioSciences Co. Ltd. (China) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global G-Protein Coupled Receptors market by Type (Cell Lines, Detection Kits, Cell Culture Reagents and Ligands), Application (Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Respiratory Research, Inflammation Research and Other Application) and Region.



On the basis of geography, the market of G-Protein Coupled Receptors has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Assay, the sub-segment i.e. CAMP Functional Assays will boost the G-Protein Coupled Receptors market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Oncology is dominating the GPCR market in terms of therapeutic areas

Market Growth Drivers:
Existence of variety of agents that stimulate GPCR activity and Increasing number of allosteric modulators, biological drugs and blased agonists that target this receptions

Challenges:
Hazardous effects of cryogenic gases and Complexity of the cryotherapy mechanisms

Restraints:
High cost involved in the maintenance of GPCR cell lines and Stringent government regulations

Opportunities:
Rising preference for minimally invasive techniques and Advancement in technology of cryotherapy equipment

Amgen's erenumab secured the FDA approval as the first G-protein coupled receptor-targeted antibody. Despite various challenges, several biologics are under the manufacturing process.
In the most cases the functional role of regulation via GRK-dependent phosphorylation remains poorly understood, the mere number of targets suggests that, in addition to playing the key role in controlling the GPCR signaling, GRKs might play important roles in cell growth, attachment and motility, cell death, proliferation and survival, immunity, cancer, as well as other pathological conditions. One example of such regulation is GRK5-dependent phosphorylation of class II histone deacetylase 5 , which plays a role in pathological cardiac hypertrophy. Another interesting substrate of GRK-dependent phosphorylation is the synuclein family comprising α-, β-, and γ-synucleins, small proteins with poorly defined functions.

Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, G-Protein Coupled Receptors Manufacturers, G-Protein Coupled Receptors Supplier & Distributor, Medicinal Research Organizations, New Entrants/Investors, Strategic Business Planners, Government Regulatory and End Use Industry

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Cell Lines
  • Detection Kits
  • Cell Culture Reagents
  • Ligands
By Application
  • Cancer Research
  • CNS Research
  • Metabolic Research
  • Cardiovascular Research
  • Respiratory Research
  • Inflammation Research
  • Other Application
By Assay
  • CAMP Functional Assays
  • Calcium Functional Assays
  • β-Arrestin Functional Assays
  • Radioligand Binding and GTPγS Functional Assays
  • Internalization Assays
  • Trafficking Assays
  • Other Assays

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Existence of variety of agents that stimulate GPCR activity
      • 3.2.2. Increasing number of allosteric modulators, biological drugs and blased agonists that target this receptions
    • 3.3. Market Challenges
      • 3.3.1. Hazardous effects of cryogenic gases
      • 3.3.2. Complexity of the cryotherapy mechanisms
    • 3.4. Market Trends
      • 3.4.1. Oncology is dominating the GPCR market in terms of therapeutic areas
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global G-Protein Coupled Receptors, by Type, Application, Assay and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global G-Protein Coupled Receptors (Value)
      • 5.2.1. Global G-Protein Coupled Receptors by: Type (Value)
        • 5.2.1.1. Cell Lines
        • 5.2.1.2. Detection Kits
        • 5.2.1.3. Cell Culture Reagents
        • 5.2.1.4. Ligands
      • 5.2.2. Global G-Protein Coupled Receptors by: Application (Value)
        • 5.2.2.1. Cancer Research
        • 5.2.2.2. CNS Research
        • 5.2.2.3. Metabolic Research
        • 5.2.2.4. Cardiovascular Research
        • 5.2.2.5. Respiratory Research
        • 5.2.2.6. Inflammation Research
        • 5.2.2.7. Other Application
      • 5.2.3. Global G-Protein Coupled Receptors by: Assay (Value)
        • 5.2.3.1. CAMP Functional Assays
        • 5.2.3.2. Calcium Functional Assays
        • 5.2.3.3. β-Arrestin Functional Assays
        • 5.2.3.4. Radioligand Binding and GTPγS Functional Assays
        • 5.2.3.5. Internalization Assays
        • 5.2.3.6. Trafficking Assays
        • 5.2.3.7. Other Assays
      • 5.2.4. Global G-Protein Coupled Receptors Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. G-Protein Coupled Receptors: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Thermo Fisher Scientific, Inc (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck Group (Germany)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. PerkinElmer, Inc (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cisbio Bioassays (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Enzo Life Sciences, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Promega Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Abcam plc (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Qiagen (Germany)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. BD (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. HD BioSciences Co. Ltd. (China)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global G-Protein Coupled Receptors Sale, by Type, Application, Assay and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global G-Protein Coupled Receptors (Value)
      • 7.2.1. Global G-Protein Coupled Receptors by: Type (Value)
        • 7.2.1.1. Cell Lines
        • 7.2.1.2. Detection Kits
        • 7.2.1.3. Cell Culture Reagents
        • 7.2.1.4. Ligands
      • 7.2.2. Global G-Protein Coupled Receptors by: Application (Value)
        • 7.2.2.1. Cancer Research
        • 7.2.2.2. CNS Research
        • 7.2.2.3. Metabolic Research
        • 7.2.2.4. Cardiovascular Research
        • 7.2.2.5. Respiratory Research
        • 7.2.2.6. Inflammation Research
        • 7.2.2.7. Other Application
      • 7.2.3. Global G-Protein Coupled Receptors by: Assay (Value)
        • 7.2.3.1. CAMP Functional Assays
        • 7.2.3.2. Calcium Functional Assays
        • 7.2.3.3. β-Arrestin Functional Assays
        • 7.2.3.4. Radioligand Binding and GTPγS Functional Assays
        • 7.2.3.5. Internalization Assays
        • 7.2.3.6. Trafficking Assays
        • 7.2.3.7. Other Assays
      • 7.2.4. Global G-Protein Coupled Receptors Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. G-Protein Coupled Receptors: by Type(USD Million)
  • Table 2. G-Protein Coupled Receptors Cell Lines , by Region USD Million (2018-2023)
  • Table 3. G-Protein Coupled Receptors Detection Kits , by Region USD Million (2018-2023)
  • Table 4. G-Protein Coupled Receptors Cell Culture Reagents , by Region USD Million (2018-2023)
  • Table 5. G-Protein Coupled Receptors Ligands , by Region USD Million (2018-2023)
  • Table 6. G-Protein Coupled Receptors: by Application(USD Million)
  • Table 7. G-Protein Coupled Receptors Cancer Research , by Region USD Million (2018-2023)
  • Table 8. G-Protein Coupled Receptors CNS Research , by Region USD Million (2018-2023)
  • Table 9. G-Protein Coupled Receptors Metabolic Research , by Region USD Million (2018-2023)
  • Table 10. G-Protein Coupled Receptors Cardiovascular Research , by Region USD Million (2018-2023)
  • Table 11. G-Protein Coupled Receptors Respiratory Research , by Region USD Million (2018-2023)
  • Table 12. G-Protein Coupled Receptors Inflammation Research , by Region USD Million (2018-2023)
  • Table 13. G-Protein Coupled Receptors Other Application , by Region USD Million (2018-2023)
  • Table 14. G-Protein Coupled Receptors: by Assay(USD Million)
  • Table 15. G-Protein Coupled Receptors CAMP Functional Assays , by Region USD Million (2018-2023)
  • Table 16. G-Protein Coupled Receptors Calcium Functional Assays , by Region USD Million (2018-2023)
  • Table 17. G-Protein Coupled Receptors β-Arrestin Functional Assays , by Region USD Million (2018-2023)
  • Table 18. G-Protein Coupled Receptors Radioligand Binding and GTPγS Functional Assays , by Region USD Million (2018-2023)
  • Table 19. G-Protein Coupled Receptors Internalization Assays , by Region USD Million (2018-2023)
  • Table 20. G-Protein Coupled Receptors Trafficking Assays , by Region USD Million (2018-2023)
  • Table 21. G-Protein Coupled Receptors Other Assays , by Region USD Million (2018-2023)
  • Table 22. South America G-Protein Coupled Receptors, by Country USD Million (2018-2023)
  • Table 23. South America G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 24. South America G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 25. South America G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 26. Brazil G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 27. Brazil G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 28. Brazil G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 29. Argentina G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 30. Argentina G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 31. Argentina G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 32. Rest of South America G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 33. Rest of South America G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 34. Rest of South America G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 35. Asia Pacific G-Protein Coupled Receptors, by Country USD Million (2018-2023)
  • Table 36. Asia Pacific G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 37. Asia Pacific G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 38. Asia Pacific G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 39. China G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 40. China G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 41. China G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 42. Japan G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 43. Japan G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 44. Japan G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 45. India G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 46. India G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 47. India G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 48. South Korea G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 49. South Korea G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 50. South Korea G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 51. Taiwan G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 52. Taiwan G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 53. Taiwan G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 54. Australia G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 55. Australia G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 56. Australia G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 57. Rest of Asia-Pacific G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 58. Rest of Asia-Pacific G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 59. Rest of Asia-Pacific G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 60. Europe G-Protein Coupled Receptors, by Country USD Million (2018-2023)
  • Table 61. Europe G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 62. Europe G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 63. Europe G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 64. Germany G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 65. Germany G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 66. Germany G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 67. France G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 68. France G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 69. France G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 70. Italy G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 71. Italy G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 72. Italy G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 73. United Kingdom G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 74. United Kingdom G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 75. United Kingdom G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 76. Netherlands G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 77. Netherlands G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 78. Netherlands G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 79. Rest of Europe G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 80. Rest of Europe G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 81. Rest of Europe G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 82. MEA G-Protein Coupled Receptors, by Country USD Million (2018-2023)
  • Table 83. MEA G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 84. MEA G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 85. MEA G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 86. Middle East G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 87. Middle East G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 88. Middle East G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 89. Africa G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 90. Africa G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 91. Africa G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 92. North America G-Protein Coupled Receptors, by Country USD Million (2018-2023)
  • Table 93. North America G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 94. North America G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 95. North America G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 96. United States G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 97. United States G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 98. United States G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 99. Canada G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 100. Canada G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 101. Canada G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 102. Mexico G-Protein Coupled Receptors, by Type USD Million (2018-2023)
  • Table 103. Mexico G-Protein Coupled Receptors, by Application USD Million (2018-2023)
  • Table 104. Mexico G-Protein Coupled Receptors, by Assay USD Million (2018-2023)
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. G-Protein Coupled Receptors: by Type(USD Million)
  • Table 116. G-Protein Coupled Receptors Cell Lines , by Region USD Million (2025-2030)
  • Table 117. G-Protein Coupled Receptors Detection Kits , by Region USD Million (2025-2030)
  • Table 118. G-Protein Coupled Receptors Cell Culture Reagents , by Region USD Million (2025-2030)
  • Table 119. G-Protein Coupled Receptors Ligands , by Region USD Million (2025-2030)
  • Table 120. G-Protein Coupled Receptors: by Application(USD Million)
  • Table 121. G-Protein Coupled Receptors Cancer Research , by Region USD Million (2025-2030)
  • Table 122. G-Protein Coupled Receptors CNS Research , by Region USD Million (2025-2030)
  • Table 123. G-Protein Coupled Receptors Metabolic Research , by Region USD Million (2025-2030)
  • Table 124. G-Protein Coupled Receptors Cardiovascular Research , by Region USD Million (2025-2030)
  • Table 125. G-Protein Coupled Receptors Respiratory Research , by Region USD Million (2025-2030)
  • Table 126. G-Protein Coupled Receptors Inflammation Research , by Region USD Million (2025-2030)
  • Table 127. G-Protein Coupled Receptors Other Application , by Region USD Million (2025-2030)
  • Table 128. G-Protein Coupled Receptors: by Assay(USD Million)
  • Table 129. G-Protein Coupled Receptors CAMP Functional Assays , by Region USD Million (2025-2030)
  • Table 130. G-Protein Coupled Receptors Calcium Functional Assays , by Region USD Million (2025-2030)
  • Table 131. G-Protein Coupled Receptors β-Arrestin Functional Assays , by Region USD Million (2025-2030)
  • Table 132. G-Protein Coupled Receptors Radioligand Binding and GTPγS Functional Assays , by Region USD Million (2025-2030)
  • Table 133. G-Protein Coupled Receptors Internalization Assays , by Region USD Million (2025-2030)
  • Table 134. G-Protein Coupled Receptors Trafficking Assays , by Region USD Million (2025-2030)
  • Table 135. G-Protein Coupled Receptors Other Assays , by Region USD Million (2025-2030)
  • Table 136. South America G-Protein Coupled Receptors, by Country USD Million (2025-2030)
  • Table 137. South America G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 138. South America G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 139. South America G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 140. Brazil G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 141. Brazil G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 142. Brazil G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 143. Argentina G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 144. Argentina G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 145. Argentina G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 146. Rest of South America G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 147. Rest of South America G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 148. Rest of South America G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 149. Asia Pacific G-Protein Coupled Receptors, by Country USD Million (2025-2030)
  • Table 150. Asia Pacific G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 151. Asia Pacific G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 152. Asia Pacific G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 153. China G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 154. China G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 155. China G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 156. Japan G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 157. Japan G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 158. Japan G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 159. India G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 160. India G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 161. India G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 162. South Korea G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 163. South Korea G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 164. South Korea G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 165. Taiwan G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 166. Taiwan G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 167. Taiwan G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 168. Australia G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 169. Australia G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 170. Australia G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 171. Rest of Asia-Pacific G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 172. Rest of Asia-Pacific G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 173. Rest of Asia-Pacific G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 174. Europe G-Protein Coupled Receptors, by Country USD Million (2025-2030)
  • Table 175. Europe G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 176. Europe G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 177. Europe G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 178. Germany G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 179. Germany G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 180. Germany G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 181. France G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 182. France G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 183. France G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 184. Italy G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 185. Italy G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 186. Italy G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 187. United Kingdom G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 188. United Kingdom G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 189. United Kingdom G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 190. Netherlands G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 191. Netherlands G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 192. Netherlands G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 193. Rest of Europe G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 194. Rest of Europe G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 195. Rest of Europe G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 196. MEA G-Protein Coupled Receptors, by Country USD Million (2025-2030)
  • Table 197. MEA G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 198. MEA G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 199. MEA G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 200. Middle East G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 201. Middle East G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 202. Middle East G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 203. Africa G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 204. Africa G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 205. Africa G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 206. North America G-Protein Coupled Receptors, by Country USD Million (2025-2030)
  • Table 207. North America G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 208. North America G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 209. North America G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 210. United States G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 211. United States G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 212. United States G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 213. Canada G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 214. Canada G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 215. Canada G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 216. Mexico G-Protein Coupled Receptors, by Type USD Million (2025-2030)
  • Table 217. Mexico G-Protein Coupled Receptors, by Application USD Million (2025-2030)
  • Table 218. Mexico G-Protein Coupled Receptors, by Assay USD Million (2025-2030)
  • Table 219. Research Programs/Design for This Report
  • Table 220. Key Data Information from Secondary Sources
  • Table 221. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global G-Protein Coupled Receptors: by Type USD Million (2018-2023)
  • Figure 5. Global G-Protein Coupled Receptors: by Application USD Million (2018-2023)
  • Figure 6. Global G-Protein Coupled Receptors: by Assay USD Million (2018-2023)
  • Figure 7. South America G-Protein Coupled Receptors Share (%), by Country
  • Figure 8. Asia Pacific G-Protein Coupled Receptors Share (%), by Country
  • Figure 9. Europe G-Protein Coupled Receptors Share (%), by Country
  • Figure 10. MEA G-Protein Coupled Receptors Share (%), by Country
  • Figure 11. North America G-Protein Coupled Receptors Share (%), by Country
  • Figure 12. Global G-Protein Coupled Receptors share by Players 2023 (%)
  • Figure 13. Global G-Protein Coupled Receptors share by Players (Top 3) 2023(%)
  • Figure 14. Global G-Protein Coupled Receptors share by Players (Top 5) 2023(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Thermo Fisher Scientific, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 17. Thermo Fisher Scientific, Inc (United States) Revenue: by Geography 2023
  • Figure 18. Merck Group (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Merck Group (Germany) Revenue: by Geography 2023
  • Figure 20. PerkinElmer, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 21. PerkinElmer, Inc (United States) Revenue: by Geography 2023
  • Figure 22. Cisbio Bioassays (France) Revenue, Net Income and Gross profit
  • Figure 23. Cisbio Bioassays (France) Revenue: by Geography 2023
  • Figure 24. Enzo Life Sciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Enzo Life Sciences, Inc. (United States) Revenue: by Geography 2023
  • Figure 26. Promega Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 27. Promega Corporation (United States) Revenue: by Geography 2023
  • Figure 28. Abcam plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 29. Abcam plc (United Kingdom) Revenue: by Geography 2023
  • Figure 30. Qiagen (Germany) Revenue, Net Income and Gross profit
  • Figure 31. Qiagen (Germany) Revenue: by Geography 2023
  • Figure 32. BD (United States) Revenue, Net Income and Gross profit
  • Figure 33. BD (United States) Revenue: by Geography 2023
  • Figure 34. HD BioSciences Co. Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 35. HD BioSciences Co. Ltd. (China) Revenue: by Geography 2023
  • Figure 36. Global G-Protein Coupled Receptors: by Type USD Million (2025-2030)
  • Figure 37. Global G-Protein Coupled Receptors: by Application USD Million (2025-2030)
  • Figure 38. Global G-Protein Coupled Receptors: by Assay USD Million (2025-2030)
  • Figure 39. South America G-Protein Coupled Receptors Share (%), by Country
  • Figure 40. Asia Pacific G-Protein Coupled Receptors Share (%), by Country
  • Figure 41. Europe G-Protein Coupled Receptors Share (%), by Country
  • Figure 42. MEA G-Protein Coupled Receptors Share (%), by Country
  • Figure 43. North America G-Protein Coupled Receptors Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific, Inc (United States)
  • Merck Group (Germany)
  • PerkinElmer, Inc (United States)
  • Cisbio Bioassays (France)
  • Enzo Life Sciences, Inc. (United States)
  • Promega Corporation (United States)
  • Abcam plc (United Kingdom)
  • Qiagen (Germany)
  • BD (United States)
  • HD BioSciences Co. Ltd. (China)
Select User Access Type

Key Highlights of Report


Feb 2024 214 Pages 68 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global G-Protein Coupled Receptors Market Quantitative research analysis
Global G-Protein Coupled Receptors Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Thermo Fisher Scientific, Inc (United States), Merck Group (Germany), PerkinElmer, Inc (United States), Cisbio Bioassays (France), Enzo Life Sciences, Inc. (United States), Promega Corporation (United States), Abcam plc (United Kingdom), Qiagen (Germany), BD (United States) and HD BioSciences Co. Ltd. (China) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Oncology is dominating the GPCR market in terms of therapeutic areas" is seen as one of major influencing trends for G-Protein Coupled Receptors Market during projected period 2023-2030.
The G-Protein Coupled Receptors market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global G-Protein Coupled Receptors Market Report?

Have a Query? Click Here

Other Related Reports

Inhalation Anesthesia Comprehensive Study by Type (Sevoflurane, Isoflurane, Desflurane, Enflurane, Halothane, Xenon, Nitrous Oxide), Application (Induction, Maintenance), Phase (Pulmonary Phase, Circ...
$ 3450
Autoimmune Treatment Comprehensive Study by Type (Drugs, Diagnostic Equipment, Therapeutic and Monitoring Equipment, Other Products), Application (Childhood, Adult), Disease Type (Localized, Systemic...
$ 3750
Baby Oral Care Comprehensive Study by Type (Toothpaste, Toothbrushes, Others), Application (Consumer use, Clinics, Hospitals), Distribution Channel (Pharmacy Store, Consumer Store, Online Retail) Pla...
$ 3500
Disposable Blood Bag Comprehensive Study by End User (Blood Banks, Hospitals, Ambulatory Centers, Non-governmental Organizations (NGOs), Others), Distribution Channel (Online, Offline (Medical Stor...
$ 3650
Medical Image Management Comprehensive Study by Application (Hospitals, Diagnostic Imaging Centers, Others), Imaging Technologies (Artificial Intelligence, Augmented Reality, Three-dimensional Printi...
$ 3750
Hygiene Adhesive Comprehensive Study by Type (Woven, Non-woven), Origin (Synthetic, Natural), End Users (Kids, Adults), Product (Sanitary Napkins, Diapers, Briefs, Absorbent Underwear, Medical Produc...
$ 3750